Does COVID‐19 contribute to development of neurological disease?
<p></p><div> <h3> Background</h3> <p>Although coronavirus disease 2019 (COVID-19) has been associated primarily with pneumonia, recent data show that the causative agent of COVID-19, the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can...
Saved in:
| Main Author: | Arehally M. Mahalakshmi (14778676) (author) |
|---|---|
| Other Authors: | Bipul Ray (14778679) (author), Sunanda Tuladhar (14601228) (author), Abid Bhat (14778682) (author), Shasthara Paneyala (14778685) (author), Duraisamy Patteswari (14778688) (author), Meena Kishore Sakharkar (7348637) (author), Hamdan Hamdan (662469) (author), David M. Ojcius (7538189) (author), Srinivasa Rao Bolla (9715874) (author), Musthafa Mohamed Essa (7348646) (author), Saravana Babu Chidambaram (7348649) (author), M. Walid Qoronfleh (14153088) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study
by: Mostafa Najim (14150400)
Published: (2022) -
Microbial Dysbiosis Tunes the Immune Response Towards Allergic Disease Outcomes
by: Tracy Augustine (14149932)
Published: (2022) -
Application of Metastructures for Targeted Low-Frequency Vibration Suppression in Plates
by: Ratiba F. Ghachi (14152455)
Published: (2022) -
Differential gene expression of tumor-infiltrating CD33<sup>+</sup> myeloid cells in advanced- versus early-stage colorectal cancer
by: Salman M. Toor (8854751)
Published: (2020) -
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review
by: Aasir M. Suliman (14150217)
Published: (2022)